Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

LONDON--(BUSINESS WIRE)-- 

Ap19

FORM 8.3 Amendment to Purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)	Barclays PLC.
Company dealt in	WILLIS TOWERS WATSON PLC
Class of relevant security to which the	ORD
dealings being disclosed relate (Note 2)
Date of dealing	29 January 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:		ORD
		Long		Short
		Number	(%)	Number	(%)
(1)	Relevant securities
		2,363,884	1.83%	605,662	0.47%
(2)	Derivatives (other than options):
		273,127	0.21%	455,399	0.35%
(3)	Options and agreements to
	purchase/sell:	6,000	0.00%	6,000	0.00%
	TOTAL:
		2,643,011	2.05%	1,067,061	0.83%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit
Purchase	1	204.2500 USD
Purchase	3	203.6333 USD
Purchase	4	203.1800 USD
Purchase	21	203.5326 USD
Purchase	23	203.7078 USD
Purchase	29	203.8400 USD
Purchase	100	203.9900 USD
Purchase	400	204.9175 USD
Purchase	584	203.3138 USD
Purchase	1,023	203.8826 USD
Purchase	1,038	203.9549 USD
Purchase	3,527	204.0332 USD
Purchase	5,698	204.1155 USD
Purchase	7,950	204.0525 USD
Purchase	12,066	203.1712 USD
Purchase	15,301	203.9371 USD
Purchase	27,610	203.9738 USD
Purchase	41,231	202.9400 USD
Sale	1	202.4400 USD
Sale	1	204.0400 USD
Sale	1	203.6100 USD
Sale	3	203.7233 USD
Sale	5	203.7000 USD
Sale	7	203.5364 USD
Sale	9	203.5766 USD
Sale	13	203.7484 USD
Sale	20	203.9100 USD
Sale	100	204.0900 USD
Sale	181	203.9355 USD
Sale	202	203.7050 USD
Sale	218	204.5509 USD
Sale	230	204.0417 USD
Sale	300	204.0800 USD
Sale	305	203.9860 USD
Sale	370	203.8124 USD
Sale	400	204.9175 USD
Sale	500	203.5750 USD
Sale	502	203.8123 USD
Sale	584	203.3138 USD
Sale	600	205.0937 USD
Sale	833	203.9142 USD
Sale	957	204.1202 USD
Sale	961	203.8843 USD
Sale	1,164	204.0811 USD
Sale	1,173	203.6912 USD
Sale	1,406	204.1804 USD
Sale	1,500	204.1043 USD
Sale	1,700	203.9608 USD
Sale	1,876	203.9013 USD
Sale	1,900	203.6752 USD
Sale	1,984	203.8424 USD
Sale	2,100	203.8819 USD
Sale	2,286	204.0384 USD
Sale	2,428	203.8656 USD
Sale	3,415	204.1069 USD
Sale	4,143	203.8810 USD
Sale	4,729	203.7127 USD
Sale	5,133	204.2172 USD
Sale	6,462	202.9405 USD
Sale	7,023	203.9677 USD
Sale	11,093	204.1103 USD
Sale	13,018	203.2267 USD
Sale	33,857	202.9400 USD

(b) Derivatives transactions (other than options transactions)

Product name, e.g. CFD

Nature of transaction (Note 6)

Number of relevant securities (Note 7)

Price per unit (Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name, e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?	YES
Date of disclosure:	3 Feb 2021
Contact name:	Large Holdings Regulatory Operations
Telephone number:	020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS
Product name	Written or	Number of	Exercise	Type	Expiry
	purchased	relevant securities	price		date
		to which the option
		or derivative
		relates
Call Options	Purchased	6,000	220.0000	American	Jul 16, 2021
Put Options	Purchased	-6,000	200.0000	American	Jul 16, 2021